An effective strategic planning and evaluation process is critical to the success of Roswell Park Cancer Institute (RPCI) in making progress towards the scientific, clinical, prevention and education missions. External and internal advisory groups provide exceptional guidance and recommendations to the CCSG Senior Leadership. Ongoing planning and evaluation is conducted through regular meetings of the CCSG External Advisory Board (EAB), program-specific EABs, Executive Council, CCSG Steering Committee, Shared Resource Advisory Committees, individual program meetings, and Institute Strategic Leadership Retreats (SLRs). Disease-Site Research Group (DSRG) meetings occur monthly and bring together preclinical and clinical investigators committed to the study of specific diseases. In addition, yearly Program and Institute-wide science retreats are held to bring together CCSG members and faculty colleagues to discuss and develop the collaborative research central to CCSG Programs. The next RPCI Science Retreat is scheduled for June 2013. Planning and Evaluation activities are critical components of successful operations at RPCI. With the use of external and internal resources, RPCI maintains exceptional science while expanding and advancing the fields of cancer research, treatment and care, and prevention. Funds requested in this application will be used to offset some of the costs of the annual CCSG EAB and program-specific EAB meetings, and the RPCI member retreat, while the remaining planning and evaluation activities will be supported by Institute resources

Public Health Relevance

These planning and evaluation activities are guided by the RPCI Strategic Plan (SP) which was developed through broad Institute faculty, staff and Board of Directors (BOD) participation. This plan laid out, based on detailed analytic information, the RPCI 10-year strategy. The SP was approved in 2009 by the BOD and is monitored specifically for progress quarterly (SLRs) and annually for overall direction. The three major components of the SP are: 1) Scientific Enhancement;2) Clinical Growth;3) Optimizing Operations.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Roswell Park Cancer Institute Corp
United States
Zip Code
Wintrob, Zachary A P; Hammel, Jeffrey P; Nimako, George K et al. (2017) Insulin use, hormone receptor status and hematopoietic cytokines? circulation in women with diabetes mellitus and breast cancer. Data Brief 11:382-390
Murphy, Maureen E; Liu, Song; Yao, Song et al. (2017) A functionally significant SNP in TP53 and breast cancer risk in African-American women. NPJ Breast Cancer 3:5
Liu, Song; Kumari, Sangeeta; Hu, Qiang et al. (2017) A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer. Elife 6:
Espinal, Allyson C; Buas, Matthew F; Wang, Dan et al. (2017) FOXA1 hypermethylation: link between parity and ER-negative breast cancer in African American women? Breast Cancer Res Treat 166:559-568
Danaher, Patrick; Warren, Sarah; Dennis, Lucas et al. (2017) Gene expression markers of Tumor Infiltrating Leukocytes. J Immunother Cancer 5:18
Oakley, Emily; Bellnier, David A; Hutson, Alan et al. (2017) Surface markers for guiding cylindrical diffuser fiber insertion in interstitial photodynamic therapy of head and neck cancer. Lasers Surg Med 49:599-608
Gage-Bouchard, Elizabeth A (2017) Social support, flexible resources, and health care navigation. Soc Sci Med 190:111-118
Moore, Kathleen N; Tritchler, David; Kaufman, Kenneth M et al. (2017) Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol 147:396-401
Szender, J Brian; Papanicolau-Sengos, Antonios; Eng, Kevin H et al. (2017) NY-ESO-1 expression predicts an aggressive phenotype of ovarian cancer. Gynecol Oncol 145:420-425
Ho, Christine M; McCarthy, Philip L; Wallace, Paul K et al. (2017) Immune signatures associated with improved progression-free and overall survival for myeloma patients treated with AHSCT. Blood Adv 1:1056-1066

Showing the most recent 10 out of 1391 publications